SCHEMBL2033047

SCHEMBL2033047

COc1ccc(C=NOc2ncc(F)c(N=CN(C)C)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GAA P10253 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
TP53 P04637 1/20 0.35
CYP2C9 P11712 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
MAPT P10636 2/20 0.33
APP P05067 2/20 0.33
APAF1 O14727 1/20 0.33
LMNA P02545 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2033045 1.00 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL12585937 1.00 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL12514917 0.89 GAA (0.33) ALDH1A1KDM4ESMN1; SMN2GAARAB9A
SCHEMBL12585943 0.88 MAPT (0.38) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL16304014 0.88 MAPT (0.38) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL2031951 0.87 KDM4E (0.33) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL12585920 0.87 KDM4E (0.33) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL2031950 0.87 KDM4E (0.33) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL13529617 0.83 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL12515060 0.81 MAPT (0.37) ALDH1A1KDM4ESMN1; SMN2GAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8912207-B2 2-aldoximino-5-fluoropyrimidine derivatives Dow AgroSciences, LLP. (US) 2014-12-16 US disclosed
WO-2011084611-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC (US) 2011-07-14 WO disclosed
US-20110152300-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152300-A1 2-ALDOXIMINO-5-FLUOROPYRIMIDINE DERIVATIVES AKR7A2, DPYD, DPM1 ALDH1A1 25/4885KDM4E 1647/4885HPGD 2221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.